146 related articles for article (PubMed ID: 22211334)
21. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of macrophage infiltration in leiomyosarcomas.
Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
[TBL] [Abstract][Full Text] [Related]
25. Atypical fibroxanthoma - what is it, what it is not.
Wilk M; Zelger B
J Cutan Pathol; 2010 Oct; 37(10):1119-20. PubMed ID: 20602661
[No Abstract] [Full Text] [Related]
26. Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy.
Koch M; Freundl AJ; Agaimy A; Kiesewetter F; Künzel J; Cicha I; Alexiou C
Anticancer Res; 2015 Nov; 35(11):5717-35. PubMed ID: 26503993
[TBL] [Abstract][Full Text] [Related]
27. Reconsidering the diagnostic and prognostic utility of LN-2 for undifferentiated pleomorphic sarcoma and atypical fibroxanthoma.
Hollmig ST; Rieger KE; Henderson MT; West RB; Sundram UN
Am J Dermatopathol; 2013 Apr; 35(2):176-9. PubMed ID: 23000905
[TBL] [Abstract][Full Text] [Related]
28. Detection of Merkel cell polyomavirus DNA in atypical fibroxanthoma in correlation to clinical features.
Andres C; Puchta U; Flaig MJ
Am J Dermatopathol; 2010 Dec; 32(8):799-803. PubMed ID: 20861707
[TBL] [Abstract][Full Text] [Related]
29. Procollagen 1 expression in atypical fibroxanthoma and other tumors.
Jensen K; Wilkinson B; Wines N; Kossard S
J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286
[TBL] [Abstract][Full Text] [Related]
30. Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.
Beer TW; Drury P; Heenan PJ
Am J Dermatopathol; 2010 Aug; 32(6):533-40. PubMed ID: 20526171
[TBL] [Abstract][Full Text] [Related]
31. Keloidal atypical fibroxanthoma: a case series.
Kim J; McNiff JM
J Cutan Pathol; 2009 May; 36(5):535-9. PubMed ID: 19476521
[TBL] [Abstract][Full Text] [Related]
32. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma.
Yoon DH; Koh YW; Kang HJ; Kim S; Park CS; Lee SW; Suh C; Huh J
Eur J Haematol; 2012 Apr; 88(4):292-305. PubMed ID: 22044760
[TBL] [Abstract][Full Text] [Related]
33. Lesional accumulation of CD163+ macrophages/microglia in rat traumatic brain injury.
Zhang Z; Zhang ZY; Wu Y; Schluesener HJ
Brain Res; 2012 Jun; 1461():102-10. PubMed ID: 22583855
[TBL] [Abstract][Full Text] [Related]
34. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains.
Zhang Z; Zhang ZY; Schittenhelm J; Wu Y; Meyermann R; Schluesener HJ
J Neuroimmunol; 2011 Aug; 237(1-2):73-9. PubMed ID: 21737148
[TBL] [Abstract][Full Text] [Related]
35. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
36. CD117 immunoreactivity in atypical fibroxanthoma.
Mathew RA; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
[TBL] [Abstract][Full Text] [Related]
37. Clear cell atypical fibroxanthoma:a clinicopathologic study.
Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
[TBL] [Abstract][Full Text] [Related]
38. Melanoma masquerading as xanthogranuloma: a diagnostic pitfall.
Idriss MH; De Jesús G; McClain SA; Gottlieb GJ
Am J Dermatopathol; 2013 May; 35(3):e41-4. PubMed ID: 23190508
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.
Shabo I; Stål O; Olsson H; Doré S; Svanvik J
Int J Cancer; 2008 Aug; 123(4):780-6. PubMed ID: 18506688
[TBL] [Abstract][Full Text] [Related]
40. Functional expression of the CD163 scavenger receptor on acute myeloid leukemia cells of monocytic lineage.
Bächli EB; Schaer DJ; Walter RB; Fehr J; Schoedon G
J Leukoc Biol; 2006 Feb; 79(2):312-8. PubMed ID: 16368951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
